Reprai 🇺🇸
About Reprai
The main product is a pharma-native AI system designed to automate and optimize operations within pharmaceutical companies, featuring three layers: intelligence, engagement, and enablement. It utilizes technologies such as market segmentation, compliance management, and AI-driven content delivery across various digital channels to enhance communication and interaction with healthcare professionals.
Reprai is a US-based company founded in 2024, now around 12 people.
Founded by Didem Aral (Founder & CEO; repeat founder; previously BİZİM DOKTOR, Digiturk; Marmara University), Özhan Öztürk (Co-Founder / COO; repeat founder; previously BİZİM DOKTOR, HORIZON Marketing Solutions Agency; Marmara University).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Round
- 212 VC — 212 is a B2B tech VC founded in Istanbul in 2011 and based in Luxembourg, with a presence in London, Doha, Dubai and San Francisco.